Associate Professor of Psychiatry, Harvard Medical School
BA, Tufts University, 1988
PhD, Yeshiva University, 1997
MPH, Harvard School of Public Health, 2007
Dr. Park is a clinical health psychologist and health services researcher who focuses on understanding and improving health-related behaviors, especially smoking cessation among vulnerable medical populations. Her research interests extend across physician and patient behavior change, the role of culture on cancer preventive behaviors and resiliency among cancer patients and providers. For her translational research in cancer prevention counseling, Dr. Park has designed and evaluated motivational interviewing interventions.
Dr. Park has published more than 100 original, peer reviewed articles. She has reviewed grant applications for the National Cancer Institute, Lance Armstrong Foundation, and the American Legacy Foundation, and she chaired the American Cancer Society’s peer review committee for Cancer Control and Prevention. Dr. Park is an expert in qualitative research development and uses qualitative research to inform quantitative survey design and intervention development. She has used mixed methods to explore cancer preventive perceptions and behaviors, cancer treatment decisions, the influence of race and ethnicity on cancer preventive behaviors and treatment decisions, and patient and physician perceptions of clinical integration of genetic testing.
Dr. Park recently completed a national study examining risk perceptions of participants enrolled in the National Lung Screening Trial. She is PI of a randomized clinical trial to examine integrating tobacco treatment into the cancer care of patients at the MGH Cancer Center and at Memorial Sloan Kettering Cancer Center. Committed to the quality of care of cancer patients and survivors, she conducted a national study to examine underinsurance issues among adult survivors of childhood cancer, as well as survivors’ familiarity with the Affordable Care Act. Though the Dana-Farber/University of Massachusetts NCI U54 collaborative grant to promote cancer disparities research, she has led two pilot studies; one examined racial differences in coping with lung cancer and a second developing a resiliency intervention for cancer center interpreters.
Dr. Park’s clinical work focuses on short-term behavioral treatment for oncology patients and survivors. In addition to her MIHP roles, she is a founding member of the MGH behavioral medicine program, serves as Director of Behavioral Health Research for the MGH Benson-Henry Institute for Mind Body Medicine as well as Director of Behavioral Sciences Research at the MGH Tobacco Research and Treatment Center Dr. Park also has several leadership roles within the Dana-Farber Harvard Cancer Center.